- Home
- Editorial
- News
- Practice Guidelines
- Anesthesiology Guidelines
- Cancer Guidelines
- Cardiac Sciences Guidelines
- Critical Care Guidelines
- Dentistry Guidelines
- Dermatology Guidelines
- Diabetes and Endo Guidelines
- Diagnostics Guidelines
- ENT Guidelines
- Featured Practice Guidelines
- Gastroenterology Guidelines
- Geriatrics Guidelines
- Medicine Guidelines
- Nephrology Guidelines
- Neurosciences Guidelines
- Obs and Gynae Guidelines
- Ophthalmology Guidelines
- Orthopaedics Guidelines
- Paediatrics Guidelines
- Psychiatry Guidelines
- Pulmonology Guidelines
- Radiology Guidelines
- Surgery Guidelines
- Urology Guidelines
FDA clears new pain management device for chronic and traumatic pain
The US Food and Drug Administration has cleared first ever pain management device for chronic and traumatic pain.
Alfa Plus is new pain management system manufactured by Solio that specifically treats pain using a tripart combination of Radio Frequency (RF), Infrared (IR), and Low Level Laser Therapy (LLLT) technologies.
Alfa Plus has been manufactured in Israel and has completed three years of research and development, conducted by Dr. Eyal Behrbalk, Head of the Orthopedic Department at The Hillel Yaffe Medical Center. The study evaluated Alfa Plus technology together with a trigger-point treatment on over 100 patients who suffered from chronic lower back pain. The results were excellent, with more than 90 percent of patients reporting significant relief from pain after treatment.
Solio Alfa Plus received Food and Drug Administration clearance in early 2019, and has already sold more than 3000 units," said Solio Founder, Shahak "Chuck" Cohen. "So, in addition to clinical success, and excellent patient testimonies regarding the relief from different types of pain — especially chronic pain, sports related injuries, pain from traumatic injury, as well as menstrual pain — we are quite confident in Alfa Plus's effectiveness."
Although RF technology is already used in advanced medical clinics, Alfa Plus focuses on safe and effective pain relief technologies that can be used directly in the home. Older devices used only temporary relief measures like TENS and soft laser LLLTs. Solio's expert team used clinical studies and consultation with pain management professionals to confirm the effectiveness of the Alfa Plus treatment.
The simple-to-use, advanced design is placed directly on the site of pain, allowing four RF diodes to noninvasively penetrate the skin with deep heating. This increases blood circulation and accelerates tissue regeneration, while reducing inflammation, muscle aches, stiffness and pain. Alfa Plus stimulates the body's natural healing mechanisms, coaxing the body into healing itself.
Solio Alfa Plus: Advanced Pain Treatment
Alfa Plus provides extended relief from both chronic and traumatic pain. Alfa Plus utilizes three specific technologies to target multiple areas of the body:
- Bi-polar RF energy: Deep penetration technology that reaches muscles and joints, increasing blood circulation while treating pain.
- IR Heat Energy: Dual optical energy (light with dual wavelengths), IR and red spectrum for treating skin pain and stiffness.
- LLLT Light Energy: Treats muscle spasms.
Solio is currently offering a 60-day money back guarantee on Alfa Plus to encourage new patients to try the device.
www.SolioTherapy.com
About DMT Ltd. and Solio
Experts in engineering and the bio-med fields, DMT Ltd. is the maker of Solio products. Solio designers have created some of the most widely used energy-based technologies and platforms in use by medical professionals. Solio specializes in a wide range of high-end professional technologies packed in small, user-friendly affordable devices intended for home use. And the Solio Beauty line offers a range of technologies for permanent hair removal, facial skin rejuvenation, skin cleansing, microdermabrasion and anti-aging, skin tightening and cellulite reduction for the body. Learn more about Solio, the Alfa Plus and other devices at www.SolioTherapy.com.
Next Story
NO DATA FOUND
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd